### Core Concept
Autoimmune hemolytic anemia (AIHA) is a condition where the immune system produces antibodies against the individual's own red blood cells, marking them for destruction. This can be seen in various hematological disorders where there is an abnormal proliferation of lymphocytes.

### Why the Correct Answer is Right
Chronic Lymphocytic Leukemia (CLL) is a type of cancer characterized by the abnormal proliferation of mature lymphocytes. In CLL, the immune system can become dysregulated, leading to the production of autoantibodies against red blood cells. These autoantibodies can bind to the red blood cells, marking them for destruction by the spleen, resulting in autoimmune hemolytic anemia. This is a common complication in CLL patients, particularly those with advanced disease.

### Why Each Wrong Option is Incorrect
**Option A:** Autoimmune hemolytic anemia is not seen in all hematological disorders, but rather is a specific complication of certain conditions like CLL.

**Option B:** Acute Myeloid Leukemia (AML) is a type of cancer that primarily affects the myeloid lineage, and autoimmune hemolytic anemia is not a characteristic feature of this disease.

**Option C:** Chronic Myeloid Leukemia (CML) is a type of cancer that affects the myeloid lineage and is characterized by the presence of the Philadelphia chromosome. While CML can lead to various complications, autoimmune hemolytic anemia is not a common feature of this disease.

### Clinical Pearl / High-Yield Fact
Autoimmune hemolytic anemia is a significant complication in CLL patients, and its presence can impact the prognosis and management of the disease. It is essential to consider AIHA in the differential diagnosis of anemia in patients with CLL.

### Correct Answer Line
✓ Correct Answer: D. CLL